Larimar Therapeutics Inc (LRMR)
2.02 -0.18 (-8.18%) 12:55 ET [NASDAQ]
2.01 x 9 2.02 x 1300
Realtime by (Cboe BZX)
2.01 x 9 2.02 x 1300
Realtime 2.01 -0.19 (-8.64%) 09:02 ET
for Thu, Apr 3rd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,604 | -36,949 | -35,355 | -50,636 | -42,482 |
| Depreciation Amortization | -4,938 | -1,532 | -456 | 312 | 165 |
| Accounts payable and accrued liabilities | 1,141 | -403 | 26 | -974 | -3,288 |
| Other Working Capital | 6,175 | -2,511 | 1,669 | 2,732 | -2,043 |
| Other Operating Activity | 7,466 | 7,936 | 6,547 | 6,461 | 5,449 |
| Operating Cash Flow | $-70,760 | $-33,459 | $-27,569 | $-42,105 | $-42,199 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -84,872 | 33,517 | -90,860 | 24,502 | -23,486 |
| PPE Investments | -515 | -164 | -100 | -333 | -62 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 41,934 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,296 |
| Investing Cash Flow | $-85,387 | $33,353 | $-90,960 | $24,169 | $17,090 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 161,883 | 30 | 75,257 | 19,885 | 75,592 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 17,995 |
| Financing Cash Flow | $161,883 | $30 | $75,257 | $19,885 | $93,587 |
| Beginning Cash Position | 28,088 | 28,164 | 71,436 | 69,487 | 1,009 |
| End Cash Position | 33,824 | 28,088 | 28,164 | 71,436 | 69,487 |
| Net Cash Flow | $5,736 | $-76 | $-43,272 | $1,949 | $68,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,760 | -33,459 | -27,569 | -42,105 | -42,199 |
| Capital Expenditure | -515 | -164 | -100 | -333 | -62 |
| Free Cash Flow | -71,275 | -33,623 | -27,669 | -42,438 | -42,261 |